What are the most common correctable facial wrinkles that can be treated with botulinum toxin type A (Botox)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most common facial wrinkles effectively treated with botulinum toxin type A (Botox)

Glabellar frown lines, horizontal forehead lines, and lateral canthal “crow’s feet” are the most common and reliably correctable dynamic facial wrinkles with botulinum toxin type A. 1, 2

  • Primary, highest-yield targets (maximal benefit to quality of life/cosmesis; strongest evidence)

    • Glabellar lines (corrugator/procerus) — FDA-approved; robust RCT/Cochrane data for efficacy and safety 1, 2
    • Lateral canthal lines (“crow’s feet”) — FDA-approved; predictable improvement, high satisfaction 1, 2
    • Horizontal forehead lines (frontalis) — common off-label but widely practiced with consistent benefit in dynamic rhytids 1, 2
  • Other commonly treated dynamic lines/areas (effective in experienced hands; augment when needed)

    • “Bunny lines” (nasalis) 3, 4
    • Perioral rhytids (orbicularis oris) and downturned oral commissures (DAO) 4, 3
    • Mentalis “cobblestone” chin 4, 3
    • Platysmal bands (neck) for contour-related lines 5, 3
    • Adjacent aesthetic concerns often paired with wrinkle treatment: brow lift effect (frontalis/depressor balance), gummy smile, masseter hypertrophy (contour) 4, 5, 3

Evidence hierarchy and rationale

  • Most recent, highest-quality synthesis: Cochrane Review (2021) confirms significant wrinkle reduction vs placebo, especially for glabellar lines; similar efficacy across leading BoNT-A brands; main serious AE risk is transient ptosis; effect ~3–5 months. This directly supports glabellar/crow’s-feet/forehead prioritization for predictable cosmetic QOL gains with low morbidity/mortality risk 1.
  • Practice data show upper-face regions (glabella, forehead, crow’s feet) are most frequently treated, aligning with patient demand and safety/efficacy profile 6, 5.
  • Clinical reviews emphasize FDA-approved cosmetic indications: glabella and crow’s feet; forehead lines are widely and effectively treated off-label in routine practice 2.

Pitfalls and how to avoid them

  • Ptosis/eyebrow drop: avoid injecting too low into the frontalis or too medial/superior near the levator; use conservative dosing in small foreheads/heavy brows 1, 2.
  • Static (etched) lines at rest respond less; consider staged BoNT-A with adjunct resurfacing/fillers if persistent 2.
  • Perioral/mouth corner work: small, precise doses to prevent speech/eating asymmetry 3, 4.
  • Neck bands: dose carefully to avoid dysphagia/voice weakness; prioritize mid-to-lower bands with superficial placement 3, 5.

Algorithm (practical)

  • Start with upper-face triad (in priority order): glabella → crow’s feet → forehead for dynamic lines; reassess at 2–4 weeks; maintain every ~3–5 months based on response and AE profile 1, 2, 6.
  • Add targeted areas (bunny lines, perioral, chin, platysma) if dynamic activity drives the wrinkle and patient desires additional improvement; use conservative, anatomically precise dosing to minimize diffusion-related AEs 3, 4.

Note: Botulism treatment guidelines and antitoxin data are not applicable to cosmetic wrinkle correction and are excluded from influencing this recommendation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.